Averia K. Flasch
- Biochemistry top 1%
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Physiology
- Cardiology and Cardiovascular Medicine
- Co-authors
- Richard J. RomanDavid E. StecKimberly M. HoaglandMark J. RiederMarija RenićJohn R. FalckDavid R. HarderKathryn Dunn
- Topics
- Eicosanoids and Hypertension Pharmacology (9 papers)Hormonal Regulation and Hypertension (6 papers)Pharmacogenetics and Drug Metabolism (3 papers)
- Journals
- HypertensionAmerican Journal of Physiology-Heart and Circulatory PhysiologyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Partner nations
- United States
In The Last Decade
Averia K. Flasch
11 papers receiving 606 citations
Peers
Comparison fields: 5 of 62
- Biochemistry 363
- Endocrinology, Diabetes and Metabolism 255
- Molecular Biology 141
- Physiology 118
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Averia K. Flasch
This map shows the geographic impact of Averia K. Flasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Averia K. Flasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Averia K. Flasch more than expected).
Fields of papers citing papers by Averia K. Flasch
This network shows the impact of papers produced by Averia K. Flasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Averia K. Flasch. The network helps show where Averia K. Flasch may publish in the future.
Co-authorship network of co-authors of Averia K. Flasch
This figure shows the co-authorship network connecting the top 25 collaborators of Averia K. Flasch. A scholar is included among the top collaborators of Averia K. Flasch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Averia K. Flasch. Averia K. Flasch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. | 39 |
| 2 | 112 | |
| 3 | 58 | |
| 4 | 119 | |
| 5 | 45 | |
| 6 | 42 | |
| 7 | 68 | |
| 8 | 34 | |
| 9 | 91 | |
| 10 | 1 | |
| 11 | 1 |
About Averia K. Flasch
Averia K. Flasch is a scholar working on Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 11 papers that have together received 610 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (9 papers), Hormonal Regulation and Hypertension (6 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Biochemistry (363 citations), Endocrinology, Diabetes and Metabolism (255 citations) and Pharmacology (110 citations). Averia K. Flasch has collaborated with scholars based in United States. Frequent co-authors include Richard J. Roman, David E. Stec, Kimberly M. Hoagland, Mark J. Rieder, Richard J. Roman, Marija Renić, John R. Falck, David R. Harder, Kathryn Dunn and Steven Ledbetter. Their work appears in journals such as Hypertension, American Journal of Physiology-Heart and Circulatory Physiology and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.